Skip to content
Open access · CC-BY via OpenAlex

Neuropathology in Mice Expressing Mouse Alpha-Synuclein

Claus Rieker, Kumlesh Kumar Dev, Katja Lehnhoff, Samuel Barbieri, Iwona Ksiazek, Sabine Kauffmann, Simone Danner, Heinrich Schell, Cindy Boden, Markus A. Rüegg, Philipp J. Kahle, Herman van der Putten, Derya R. Shimshek

PLoS ONE · 2011 · ▲ 168 citations

Abstract

α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express mαSN in central neurons at levels reaching up to six-fold compared to endogenous mαSN. Unlike transgenic mice expressing human wildtype or mutant forms of αSN, these mαSN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of mαSN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated αSN occurred in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated αSN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in mαSN transgenic mice, was similar to what we have reported for mice expressing human αSN wildtype or mutant forms. In hippocampal neurons, the mαSN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human αSN, mαSN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype mαSN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1371/journal.pone.0024834
Canonical
link ↗
Fetched
2026-10-21 MST

Cite this

APA
Rieker, C., Dev, K.K., Lehnhoff, K., Barbieri, S., Ksiazek, I., Kauffmann, S., Danner, S., Schell, H., Boden, C., Rüegg, M.A., Kahle, P.J., Putten, H.V.D., &amp; Shimshek, D.R. (2011). Neuropathology in Mice Expressing Mouse Alpha-Synuclein. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0024834
Vancouver
Rieker C, Dev KK, Lehnhoff K, Barbieri S, Ksiazek I, Kauffmann S, et al. Neuropathology in Mice Expressing Mouse Alpha-Synuclein. PLoS ONE. 2011. doi:10.1371/journal.pone.0024834.
BibTeX
@article{claus2011Neurop, title = {Neuropathology in Mice Expressing Mouse Alpha-Synuclein}, author = {Claus Rieker and Kumlesh Kumar Dev and Katja Lehnhoff and Samuel Barbieri and Iwona Ksiazek and Sabine Kauffmann and Simone Danner and Heinrich Schell and Cindy Boden and Markus A. Rüegg and Philipp J. Kahle and Herman van der Putten and Derya R. Shimshek}, journal = {PLoS ONE}, year = {2011}, doi = {10.1371/journal.pone.0024834}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings